Prediction and characterisation of the human B cell response to a heterologous two-dose Ebola vaccine.
O'Connor D. et al, (2025), Nat Commun, 16
Antibiotic use attributable to RSV infections during infancy - an international prospective birth cohort study
Hak SF. et al, (2025), Journal of Antimicrobial Chemotherapy, 80, 1803 - 1812
Placental transfer of SARS-CoV-2 antibodies in mother-neonate pairs: a prospective nested cohort study.
Mugo AG. et al, (2025), BMC Infect Dis, 25
A Systematic Review on Patient and Public Attitudes Toward Health Monitoring Technologies Across Countries
Chen T. et al, (2025), npc digital medicine
Two distinct subpopulations of human stem-like memory T cells exhibit complementary roles in self-renewal and clonal longevity.
Koftori D. et al, (2025), PLoS Biol, 23
LISTEN: lived experiences of Long COVID: a social media analysis of mental health and supplement use
Martin S. et al, (2025), Frontiers in Big Data, 8
Respiratory viral detection in children hospitalized with pneumonia during periods of major population disruptions in Nepal, 2014-2018.
Shrestha S. et al, (2025), J Pediatric Infect Dis Soc
The waning of maternal measles antibodies: a multi-country maternal-infant seroprevalence study.
Tiley KS. et al, (2025), J Infect
180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trial.
Munro APS. et al, (2025), Lancet Child Adolesc Health, 9, 404 - 412
Real-world uptake of nirsevimab, RSV maternal vaccine, and RSV vaccines for older adults: a systematic review and meta-analysis
Trusinska D. et al, (2025), Eclinicalmedicine, 84
The TyphiNET data visualisation dashboard: unlocking Salmonella Typhi genomics data to support public health.
Dyson ZA. et al, (2025), Genome Med, 17
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine
Dold C. et al, (2025), Science Translational Medicine, 17
Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries.
Ibarz-Pavon AB. et al, (2025), Vaccine, 56
Effectiveness of biomarker-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection: the BATCH RCT.
Waldron C-A. et al, (2025), Health Technol Assess, 29, 1 - 125
Severe Parvovirus B19-Associated Myocarditis in Children in the Post-COVID-19 Era: A Multicenter Observational Cohort Study.
Russell N. et al, (2025), Open Forum Infect Dis, 12
CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade
Milotay G. et al, (2025), Nature Medicine
Author Correction: Immunogenic recombinant Mayaro virus-like particles present natively assembled glycoprotein.
Kim YC. et al, (2025), NPJ Vaccines, 10